Insider Buying: Radiopharm Theranostics Limited (ASX:RAD) Insider Purchases 1,300,000 Shares of Stock

Radiopharm Theranostics Limited (ASX:RAD) insider Ian Turner bought 1,300,000 shares of Radiopharm Theranostics stock in a transaction dated Wednesday, February 19th. The stock was purchased at an average cost of A$0.03 ($0.02) per share, for a total transaction of A$33,800.00 ($20,993.79).

Radiopharm Theranostics Price Performance

The firm has a market capitalization of $60.78 million, a PE ratio of -0.19 and a beta of 0.82.

About Radiopharm Theranostics

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.